123 related articles for article (PubMed ID: 38301745)
1. Analysis of bacteremia at first-line antibiotic treatment for febrile neutropenia in children and adolescents: A retrospective, single-center analysis.
Kobayashi R; Sano H; Matsushima S; Hori D; Yanagi M; Suzuki D
J Infect Chemother; 2024 Jul; 30(7):642-645. PubMed ID: 38301745
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic susceptibility of Gram-negatives isolated from bacteremia in children with cancer. Implications for empirical therapy of febrile neutropenia.
Castagnola E; Caviglia I; Pescetto L; Bagnasco F; Haupt R; Bandettini R
Future Microbiol; 2015; 10(3):357-64. PubMed ID: 25812459
[TBL] [Abstract][Full Text] [Related]
3. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
4. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in febrile neutropenic children.
Han SB; Jung SW; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK; Park YJ
Microb Drug Resist; 2015 Apr; 21(2):244-51. PubMed ID: 25398058
[TBL] [Abstract][Full Text] [Related]
5. Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols.
Greenberg D; Moser A; Yagupsky P; Peled N; Hofman Y; Kapelushnik J; Leibovitz E
Int J Antimicrob Agents; 2005 Jun; 25(6):469-73. PubMed ID: 15890499
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of cycling empirical antibiotic therapy for febrile neutropenia in pediatric cancer patients.
Teranishi H; Koga Y; Nishio H; Kato W; Ono H; Kanno S; Nakashima K; Takada H
J Infect Chemother; 2017 Jul; 23(7):463-467. PubMed ID: 28527651
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
Chong Y; Shimoda S; Yakushiji H; Ito Y; Miyamoto T; Kamimura T; Shimono N; Akashi K
PLoS One; 2013; 8(1):e54190. PubMed ID: 23372683
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia in children with febrile neutropenia.
Han SB; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK
Infection; 2013 Oct; 41(5):917-24. PubMed ID: 23640200
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
[TBL] [Abstract][Full Text] [Related]
11. Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia--species distribution and susceptibility patterns.
Miedema KG; Winter RH; Ammann RA; Droz S; Spanjaard L; de Bont ES; Kamps WA; van de Wetering MD; Tissing WJ
Support Care Cancer; 2013 Sep; 21(9):2417-26. PubMed ID: 23579946
[TBL] [Abstract][Full Text] [Related]
12. Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).
El Omri H; Padmanabhan R; Taha RY; Kassem N; Elsabah H; Ellahie AY; Santimano AJJ; Al-Maslamani MA; Omrani AS; Elomri A; El Omri A
J Infect Public Health; 2024 Jan; 17(1):152-162. PubMed ID: 38029491
[TBL] [Abstract][Full Text] [Related]
13. Pediatric fever in neutropenia with bacteremia-Pathogen distribution and in vitro antibiotic susceptibility patterns over time in a retrospective single-center cohort study.
Stergiotis M; Ammann RA; Droz S; Koenig C; Agyeman PKA
PLoS One; 2021; 16(2):e0246654. PubMed ID: 33577566
[TBL] [Abstract][Full Text] [Related]
14. Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients.
Rönkkö R; Juutilainen A; Koivula I; Vänskä M; Nousiainen T; Jantunen E; Hämäläinen S
Infect Dis (Lond); 2018 Jun; 50(6):436-442. PubMed ID: 29303041
[TBL] [Abstract][Full Text] [Related]
15. Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia.
Ben-Chetrit E; Eldaim MA; Bar-Meir M; Dodin M; Katz DE
Int J Antimicrob Agents; 2019 Apr; 53(4):423-428. PubMed ID: 30572008
[TBL] [Abstract][Full Text] [Related]
16. Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia.
Kleinhendler E; Cohen MJ; Moses AE; Paltiel O; Strahilevitz J; Cahan A
Int J Antimicrob Agents; 2018 Jan; 51(1):71-76. PubMed ID: 28705670
[TBL] [Abstract][Full Text] [Related]
17. Bloodstream infection in cancer patients; susceptibility profiles of the isolated pathogens, at Khartoum Oncology Hospital, Sudan.
Zain OM; Elsayed MY; Abdelkhalig SM; Abdelaziz M; Ibrahim SY; Bashir T; Hamadalnil Y
Afr Health Sci; 2022 Dec; 22(4):70-76. PubMed ID: 37092093
[TBL] [Abstract][Full Text] [Related]
18. Meropenem versus piperacillin/tazobactam for febrile neutropenia in pediatric patients: efficacy of piperacillin/tazobactam as a 1-h drip infusion four times a day.
Kobayashi R; Sano H; Matsushima S; Hori D; Yanagi M; Kodama K; Suzuki D; Kobayashi K
Int J Hematol; 2021 Mar; 113(3):430-435. PubMed ID: 33170417
[TBL] [Abstract][Full Text] [Related]
19. Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia.
Ariffin H; Navaratnam P; Mohamed M; Arasu A; Abdullah WA; Lee CL; Peng LH
Int J Infect Dis; 2000; 4(1):21-5. PubMed ID: 10689210
[TBL] [Abstract][Full Text] [Related]
20. Meropenem versus piperacillin-tazobactam as empiric therapy for febrile neutropenia in pediatric oncology patients.
Sezgin G; Acipayam C; Ozkan A; Bayram I; Tanyeli A
Asian Pac J Cancer Prev; 2014; 15(11):4549-53. PubMed ID: 24969883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
